Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Lorini

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Dermatology Practical & Conceptual|December 8, 2021
Treatment of Cutaneous Squamous Cell Carcinoma with Immune Checkpoint Inhibitors in Special PopulationsPaolo Bossi, Luigi Lorini
Current Opinion in Otolaryngology & Head and Neck Surgery|January 4, 2021
Oral potentially malignant disorders: new insights for future treatmentCrisitna Gurizzan, Luigi Lorini, Paolo Bossi
Dermatology Practical & Conceptual|November 22, 2023
Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New ChallengesLuigi Lorini, Andrea Alberti, Paolo Bossi
Frontiers in Oncology|April 23, 2024
Human Papilloma Virus (HPV) driven oropharyngeal cancer in current or previous heavy smokers: should we look for a different treatment paradigm?Luigi Lorini, Paolo Bossi, Amanda Psyrri, et al.
Drugs & Aging|January 30, 2023
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in Older Patients: Are New Agents Bringing New Hope?Maria Cossu Rocca, Luigi Lorini, Petr Szturz, et al.
Oral Oncology|May 10, 2024
The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysisAlberto Paderno, Fausto Petrelli, Luigi Lorini, et al.
Frontiers in Oncology|February 14, 2022
Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer GroupKonrad Klinghammer, Luigi Lorini, Daan Nevens, et al.
Journal for Immunotherapy of Cancer|August 25, 2021
Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy?Paolo Bossi, Cristina Gurizzan, Luigi Lorini, et al.
Frontiers in Oncology|July 16, 2026
Rethinking smoking assessment in head and neck squamous cell carcinoma: are we missing something?Riccardo Gili, Luigi Lorini, Davide Smussi, et al.
Frontiers in Oncology|November 25, 2024
Diving into hot topics of salivary gland carcinoma management-an EORTC young and early career investigator surveyLuigi Lorini, Sara Ronchi, Daan Nevens, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Dermatology Practical & Conceptual|December 8, 2021
Treatment of Cutaneous Squamous Cell Carcinoma with Immune Checkpoint Inhibitors in Special PopulationsPaolo Bossi, Luigi Lorini
Current Opinion in Otolaryngology & Head and Neck Surgery|January 4, 2021
Oral potentially malignant disorders: new insights for future treatmentCrisitna Gurizzan, Luigi Lorini, Paolo Bossi
Dermatology Practical & Conceptual|November 22, 2023
Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New ChallengesLuigi Lorini, Andrea Alberti, Paolo Bossi
Frontiers in Oncology|April 23, 2024
Human Papilloma Virus (HPV) driven oropharyngeal cancer in current or previous heavy smokers: should we look for a different treatment paradigm?Luigi Lorini, Paolo Bossi, Amanda Psyrri, et al.
Drugs & Aging|January 30, 2023
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in Older Patients: Are New Agents Bringing New Hope?Maria Cossu Rocca, Luigi Lorini, Petr Szturz, et al.
Oral Oncology|May 10, 2024
The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysisAlberto Paderno, Fausto Petrelli, Luigi Lorini, et al.
Frontiers in Oncology|February 14, 2022
Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer GroupKonrad Klinghammer, Luigi Lorini, Daan Nevens, et al.
Journal for Immunotherapy of Cancer|August 25, 2021
Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy?Paolo Bossi, Cristina Gurizzan, Luigi Lorini, et al.
Frontiers in Oncology|July 16, 2026
Rethinking smoking assessment in head and neck squamous cell carcinoma: are we missing something?Riccardo Gili, Luigi Lorini, Davide Smussi, et al.
Frontiers in Oncology|November 25, 2024
Diving into hot topics of salivary gland carcinoma management-an EORTC young and early career investigator surveyLuigi Lorini, Sara Ronchi, Daan Nevens, et al.
Pageof 5